Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEARW
Pear Therapeutics, Inc.US flagNASDAQ Capital Market
0.01
USD
- -
- -
-10.10EPS
0.00P/E
4.09MMarket Cap
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Corey M. McCann
Full Time Employees
200
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
200 State Street Boston MA United States of America 02109
Similar Companies
Business
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.